Second, through the identification of non-canonical, IRF-mediated IKK-signalling pathway, resulting in increased pS13 HTT levels distinct from the canonical, IKK complex–mediated pathway, whose activity contributes to HD and to regulation of HTT expression. This evidence concerns the gene TRIM63 and Huntington disease.